ST. LOUIS, May 28, 2025 /PRNewswire/ — Panome Bio, a leading provider of multi-omic services, has added transcriptional profiling to its suite of discovery tools. “The full-service RNAseq workflow is ideal for biomarker discovery and mechanism of action studies and well-suited for integration with Panome Bio’s metabolomics and proteomics assays. With this new transcriptomics offering Panome Bio completes its premium discovery toolkit, allowing for integrated multi-omics analysis of all dynamic analytes downstream of the static genome.”
“At Panome Bio, we recognize that a complete picture of biological processes requires looking beyond a single layer of information,” explains Edward Weinstein, CEO of Panome Bio. “Our new transcriptomics services integrate with proteomics and metabolomics data, providing researchers with a powerful approach to unravel complex biological questions in fields from discovery research through early-stage clinical trials.”
Panome bio’s newest service is a complete RNAseq solution, going from sample preparation through data analysis that includes differential expression and pathway analysis as well as expert data interpretation. The transcriptional profiling service requires minimal sample inputs and offers customized workflows designed for a variety of sample types. It is a high throughput and scalable option suitable for large cohort studies. By integrating gene expression data with metabolite and protein profiles, researchers see improved biomarker discovery, enhanced pathway elucidation and increased confidence in findings.
About Panome Bio:
Panome Bio is a contract research organization performing metabolomics, proteomics, transcriptomics, and integrated multi-omics data analysis to help clients further their research in disease and drug development. Panome Bio provides a comprehensive workflow including experimental design, sample preparation and analysis, and data processing. For more information, please visit our website, follow us on LinkedIn, or email at info@panomebio.com.
Contact Information:
Alexandra Harrison
Director of Marketing, Panome Bio
Alexandra.harrison@panomebio.com
(314) 632-6588
SOURCE Panome Bio
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…